Overview
This algorithm can be used as a guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease—namely coronary artery disease, peripheral arterial disease, and cerebrovascular disease.
This Guidelines summary has been reproduced with permission from the Cardio-Renal-Metabolic (CaReMeUK) Partnership of the Association of British Clinical Diabetologists, the British Cardiovascular Society, the Primary Care Cardiovascular Society, the Primary Care Diabetes Society, and the Renal Association.
Algorithm 1: Cardiovascular Risk Optimisation in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
References
References